Oxaliplatin: a review in the era of molecularly targeted therapy.

@article{Alcindor2011OxaliplatinAR,
  title={Oxaliplatin: a review in the era of molecularly targeted therapy.},
  author={Thierry Alcindor and N. Beauger},
  journal={Current oncology},
  year={2011},
  volume={18 1},
  pages={18-25}
}
OBJECTIVE To review preclinical and clinical data for oxaliplatin in the current context of molecularly targeted therapy. METHODS OF STUDY SELECTION We searched the PubMed and PubChem databases by combining the search terms "oxaliplatin" or "platinum" or both, with "clinical trials," "pharmacokinetics," and "pharmacodynamics." DATA EXTRACTION AND SYNTHESIS Oxaliplatin has a complicated pharmacokinetic profile, with activity against digestive cancers in particular. It has several mechanisms… CONTINUE READING
50 Citations
60 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 50 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 60 references

Randomized phase 3 study of panitumumab with folfox4 compared to folfox4 alone as 1st-line treatment (tx) for metastatic colorectal cancer (mcrc): the prime trial [abstract 10LBA

  • J Douillard, S Siena, J Cassidy
  • Eur J Cancer 2009;7(suppl):6. [Available online…
  • 2010

Similar Papers

Loading similar papers…